Dr. Declan Doogan, MD, a co-founder of Juvenescence, was driven to start the company because he believes we all can do better in managing health as we get older.

Dr. Doogan has more 30 years’ experience in the global pharmaceutical industry. He was Head of Worldwide Drug Development at Pfizer, working in the US, UK and Japan. Dr. Doogan was also head of R&D at Amarin where he helped raise $100m to fund the reorganization and portfolio realignment leading to the NDA approval for Vascepa (icosapent ethyl) for elevated triglycerides.

During his career, Declan has engaged in activities to promote excellence in pharmaceutical medicine and sits on the boards of several biotechnology companies and multiple pharmaceutical companies. He is Chairman and co-founder of Biohaven Pharmaceuticals, Portage Biotech, and PHPrecisionmed.